Autoimmune Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029

  • Single User License $3500

Autoimmune Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029

Status : July, 2020 | Pharmaceutical | PPT format

Report Digest

Global Autoimmune Disease Diagnostics Market: Overview

Autoimmune disease diagnostics market has gained traction due to growing efforts by several vendors undertaking research activities to discover novel biomarkers. Type 1 diabetes, multiple sclerosis, and Addison’s disease are some examples of autoimmune diseases. In these disease conditions, the immune system of an individual mistakenly attacks their own body. Growing instances of autoimmune diseases among worldwide population is fueling the growth of the autoimmune disease diagnostics market.

Broadly, the segmentation of the autoimmune disease diagnostics market performed based on product, types, end-users, and regions. Based on types, the market is bifurcated into localized autoimmune disease diagnostics and systemic autoimmune disease diagnostics. Further, assay kits and analyzers are products available in the market.

Global Autoimmune Disease Diagnostics Market: Growth Dynamics

Increased demand for test kits for autoimmune disease globally is triggering the growth of market. Growing initiatives to spread awareness about autoimmune disease is one of the driving factors for the market. For instance, the American autoimmune related diseases association (AARDA) is a nonprofit organization focused on spreading awareness about autoimmune diseases. The organization carries out different programs for this purpose. This increased awareness about the disease is expected to support the market growth.

Many vendors in the market are investing in research activities to offer innovative products that provide precise results. Besides, they are growing efforts to expand regional reach by numerous strategies such as mergers and acquisitions, collaborations, and partnerships. All these efforts are projected to spur the growth of the global autoimmune disease diagnostics market during coming years. Many insurance companies offer coverage for autoimmune diseases. This has opened access for many people to get treatment for these disease conditions, which in turn is pushing the growth of the global autoimmune disease diagnostics market.

Global Autoimmune Disease Diagnostics Market: Notable Development and Competitive Landscape

The autoimmune disease diagnostics market is witnessing tremendous growth opportunities. Numerous companies involved in the market are chasing mergers and acquisition strategies. For instance, Danaher Corporation announced the acquisition of the Biopharma business from General Electric Company's Life Sciences division. This move by the firm is expected to have a positive impact on the market growth.

Many vendors are entering into partnerships to offer highly improved products. A case in point here is latest partnership announcement from Exagen Inc. Partners and Sonora Quest Laboratories. The main motive of this partnership is to provide AVISE testing for patients suspected of autoimmune disease. This strategy by both companies will propel the global autoimmune disease diagnostics market.

The autoimmune disease diagnostics market is highly fragmented due to the presence of numerous international and local players contributing to its growth. The list of important players includes:

  • bioMérieux SA
  • Abbott Laboratories
  • Danaher Corp.
  • Bio-Rad Laboratories Inc.
  • Hemagen Diagnostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • HOB Biotech Group Corp.
  • Siemens AG
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc.

Global Autoimmune Disease Diagnostics Market: Regional Assessment

Among the key regions, North America is expected to continue its dominance in the market for autoimmune disease diagnostics due to growing instances of autoimmune diseases. Moreover, increased accessibility to medical insurance to major US population is one of the important factors boosting the market growth. Asia Pacific is expected to show prominent growth avenues for the global autoimmune disease diagnostics market. The key reason behind this estimation is said to be the presence of emerging economies such as India, China, and Japan.

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.